Invention Grant
US11767503B2
有权
- Patent Title:
-
Application No.: US17762014Application Date: 2021-02-02
-
Publication No.: US11767503B2Publication Date: 2023-09-26
- Inventor: Xiaolei Ze , Xuguang Zhang , Ruikun He , Fang He
- Applicant: BYHEALTH CO., LTD.
- Applicant Address: CN Guangdong
- Assignee: BYHEALTH CO., LTD.
- Current Assignee: BYHEALTH CO., LTD.
- Current Assignee Address: CN Guangdong
- Agency: MEDLER FERRO WOODHOUSE & MILLS PLLC
- Priority: CN 2010858666.6 2020.08.24
- International Application: PCT/CN2021/074857 2021.02.02
- International Announcement: WO2022/041658A 2022.03.03
- Date entered country: 2022-03-18
- Main IPC: C12N1/20
- IPC: C12N1/20 ; A23L33/135 ; A61P37/08 ; A61P29/00 ; A61K9/00 ; A61K35/745 ; C12N1/16 ; C12R1/01 ; A61K35/00
Abstract:
The present application relates to a Bifidobacterium breve or progeny thereof. Specifically, the present application relates to Bifidobacterium breve 207-1 and a composition, culture, food product or dietary supplement containing the same. The present application also relates to the use of Bifidobacterium breve 207-1 and the composition, culture, food product or dietary supplement containing the same in medicine.
Public/Granted literature
- US20220333062A1 BIFIDOBACTERIUM BREVE 207-1 AND USE THEREOF Public/Granted day:2022-10-20
Information query
IPC分类:
